 |
市場調查報告書
商品編碼
1608872
糖尿病照護市場：依產品類型（血糖監測設備、胰島素幫浦）、以糖尿病類型、依最終使用者、按地區Diabetes Care Market, By Product Type (Glucose Monitoring Devices, Insulin Pumps, By Diabetes Type, By End User, By Geography |
||||||
糖尿病照護市場預計到2024年將達到316.9億美元，預計到2031年將達到568.6億美元，2024年至2031年的複合年成長率為8.7%。
| 分析範圍 | 分析詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 市場規模（2024年） | 316.9億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024-2031 |
| 預測期複合年成長率（2024-2031） | 8.70% | 預計金額（2031年） | 568.6億美元 |
糖尿病是一種慢性代謝疾病，影響身體利用葡萄糖的方式。診斷患有糖尿病的人數每年都在穩定增加。根據國際糖尿病聯盟2022年7月的數據，2021年將有超過5.37億成年人患有糖尿病，預計2045年將增加至7億。這種疾病的日益普及增加了全球對糖尿病照護產品和服務的需求。糖尿病照護市場包括血糖值監測設備（如血糖儀、試紙、採血針和監測系統）、胰島素輸送設備（如胰島素筆、幫浦和注射器）以及糖尿病管理應用程式和軟體。
市場動態：
全球糖尿病照護市場的成長是由糖尿病患者數量的增加、糖尿病自我管理意識的提高、糖尿病管理技術的進步以及政府遏製糖尿病負擔的舉措所推動的。然而，高昂的設備成本、許多國家有限的醫療報銷以及某些設備讀數不準確的風險正在限制市場成長。同時，自動調節血糖值的人工胰腺裝置的市場開拓、口服胰島素製劑的持續研發以及胰島細胞移植正在為市場創造利潤豐厚的機會。
本研究的主要特點
該報告對全球糖尿病護理市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
根據公司亮點、產品系列、主要亮點、績效和策略等參數對全球糖尿病護理市場的主要企業進行了分析。
主要公司包括 Medtronic、Abbott、Pumps It, Inc.、Embecta Corp.、Insulet Corporation、Ypsomed AG、Roche AG、Tandem Diabetes Care, Inc.、Terumo、Novo Nordisk A/S、SOOIL Developments Co. Ltd.。 ViCentra BV、CeQur Corporation、Dexcom, Inc. 等。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球糖尿病護理市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球糖尿病照護市場的各種策略矩陣，將有助於相關人員做出決策。
目錄
第1章 分析目的與前提
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管場景
- 產品發布/核准
- PEST分析
- 波特的分析
- 企業合併(M&A) 場景
- 流行病學
- 市場趨勢
第 4 章 全球糖尿病照護市場：按產品類型分類，2019-2031 年（十億美元）
- 血糖監測裝置
- 胰島素幫浦
- 貼片幫浦
- 繫繩幫浦
- 植入式胰島素泵
- 其他（胰島素注射器、筆針等）
第5章 全球糖尿病照護市場：依糖尿病類型分類，2019-2031 年（十億美元）
- 2型糖尿病
- 1型糖尿病
- 其他（如妊娠糖尿病）
第6章 全球糖尿病照護市場：以最終用戶分類，2019-2031 年（十億美元）
- 醫院/診所
- 居家醫療
- 門診就診環境
- 其他（學術研究機構、臨床實驗室等）
第7章 全球糖尿病照護市場：按地區分類，2019-2031 年（十億美元）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第8章 競爭格局
- Medtronic
- Abbott
- Pumps It, Inc.
- Embecta Corp
- Insulet Corporation
- Ypsomed AG
- Roche AG
- Tandem Diabetes Care, Inc.
- Terumo
- Novo Nordisk A/S
- SOOIL Developments Co., Ltd
- Microtec Medical Ltd
- ViCentra BV
- CeQur Corporation
- Dexcom, Inc.
第9章 分析師建議
- 《命運之輪》
- 分析師觀點
- Coherent Opportunity Map (COM)
第10章 參考文獻與調查方法
- 參考
- 分析方法
- 關於相干市場洞察
The diabetes care market is estimated to be valued at USD 31.69 billion in 2024 and is expected to reach USD 56.86 billion by 2031, exhibiting a compound annual growth rate (CAGR) of 8.7% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | 31.69 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 8.70% | 2031 Value Projection: | 56.86 Bn |
Diabetes is a chronic metabolic disease that affects how the body utilizes glucose. The number of people diagnosed with diabetes has been steadily increasing over the years. In July 2022, according to the International Diabetes Federation, over 537 million adults were living with diabetes in 2021 which is projected to grow to 700 million by 2045. The rising prevalence of the disease has led to an increased demand for diabetes care products and services globally. The diabetes care market covers blood glucose monitoring devices like glucometers, test strips, lancets and monitoring systems, insulin delivery devices like insulin pens, pumps, and injectors, and diabetes management apps and software.
Market Dynamics:
The global diabetes care market growth is driven by the growing diabetes patient pool, increasing awareness about diabetes self-management, advancement of diabetes management technologies, and government initiatives to curb the burden of the disease. However, high device costs, limited medical reimbursement in many countries, and risk of inaccurate readings with some devices restrain the market growth. On the other hand, development of artificial pancreas devices that automatically regulate blood glucose levels, ongoing R&D to develop oral insulin formulations, and islet cell transplantations create lucrative opportunities in the market.
Key Features of the Study:
This report provides in-depth analysis of the global diabetes care market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diabetes care market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, Abbott, Pumps It, Inc., Embecta Corp, Insulet Corporation, Ypsomed AG, Roche AG, Tandem Diabetes Care, Inc., Terumo, Novo Nordisk A/S, SOOIL Developments Co., Ltd, Microtec Medical Ltd, ViCentra B.V., CeQur Corporation, and Dexcom, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global diabetes care market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes care market
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2019 - 2031)
- Glucose Monitoring Devices
- Blood glucose monitoring (BGM)
- Continuous glucose monitoring (CGM)
- Flash glucose monitoring (FGM)
- Insulin Pumps
- Patch pump
- Tethered pump
- Implanted insulin pump
- Others (Insulin Syringes, Pen Needles, etc.)
- Diabetes Type Insights (Revenue, USD Bn, 2019 - 2031)
- Type 2 Diabetes
- Type 1 Diabetes
- Other (Gestational Diabetes, etc.)
- End User Insights (Revenue, USD Bn, 2019 - 2031)
- Hospitals & Clinics
- Homecare Settings
- Ambulatory Care Settings
- Others (Academic and Research Institutes, Clinical Laboratories, etc.)
- Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Medtronic
- Abbott
- Pumps It, Inc.
- Embecta Corp
- Insulet Corporation
- Ypsomed AG
- Roche AG
- Tandem Diabetes Care, Inc.
- Terumo
- Novo Nordisk A/S
- SOOIL Developments Co., Ltd
- Microtec Medical Ltd
- ViCentra B.V.
- CeQur Corporation
- Dexcom, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Diabetes Care Market, By Product Type
- Diabetes Care Market, By Diabetes Type
- Diabetes Care Market, By End User
- Diabetes Care Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Epidemiology
- Market Trends
4. Global Diabetes Care Market, By Product Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Glucose Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Blood glucose monitoring (BGM)
- Continuous glucose monitoring (CGM)
- Flash glucose monitoring (FGM)
- Insulin Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Patch pump
- Tethered pump
- Implanted insulin pump
- Others (Insulin Syringes, Pen Needles, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
5. Global Diabetes Care Market, By Diabetes Type, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Type 2 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Type 1 Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Other (Gestational Diabetes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Diabetes Care Market, By End User, 2019-2031, (USD Bn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Ambulatory Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others (Academic and Research Institutes, Clinical Laboratories, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Diabetes Care Market, By Region, 2019 - 2031, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Diabetes Type, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By End User, 2019 - 2031, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pumps It, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Embecta Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Insulet Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ypsomed AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tandem Diabetes Care, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Terumo
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novo Nordisk A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SOOIL Developments Co., Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Microtec Medical Ltd
- ViCentra B.V.
- CeQur Corporation
- Dexcom, Inc.
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About us
